IL17A and familial Mediterranean fever: Future studies and clinical trials investigating the effect of anti-cytokine therapy in FMF should include a more representative heterogenous sample with longer follow-up durations and a wider scope of biologics (anti-IL-17, anti-IL-18, etc.).